Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
04/14/2004 | EP1406610A1 Use of substituted gamma-lactone compounds as medicaments |
04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
04/14/2004 | EP1406607A2 Verwendung einer antiviralen verbindungsklasse (dithiocarbamat-verbindungen) zur herstellung eines mittels zur behandlung bzw. pravention einer virusinfektion im respiratorischen trakt |
04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
04/14/2004 | EP1406572A2 Pediatric formulation of gatifloxacin |
04/14/2004 | EP1286954B1 7-substituted fused ring tetracycline compounds |
04/14/2004 | EP1202994B1 New compounds |
04/14/2004 | EP1200419B1 Aminothiazole derivatives and their use as crf receptor ligands |
04/14/2004 | EP1189583A4 Indole derivatives |
04/14/2004 | EP1181038B1 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
04/14/2004 | EP1156054B1 Drugs containing phosphoric acid derivatives as the active ingredient |
04/14/2004 | EP1140072B1 Compounds and methods |
04/14/2004 | EP1073662B1 Process for preparing (-)pyridobenzoxazine carboxylic acid derivatives |
04/14/2004 | EP1073655B1 Pharmaceutically available protoberberine salts derivatives, and protoberberine derivatives and salts thereof |
04/14/2004 | EP1054867B1 Antivirals |
04/14/2004 | EP0948495B1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
04/14/2004 | EP0925298B1 Substituted 6,6-hetero-bicyclic derivatives |
04/14/2004 | CN1489630A HIV-like particles and use thereof |
04/14/2004 | CN1489628A Compounds and methods for treatment and diagnosis of chlamydial infection |
04/14/2004 | CN1489589A Novel carbapenem compounds |
04/14/2004 | CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes |
04/14/2004 | CN1489586A Indazolyl-substituted pyrroline compounds as kinase inhibitor |
04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
04/14/2004 | CN1489580A Imidazole derivatives |
04/14/2004 | CN1489576A Cannabinod receptor ligands |
04/14/2004 | CN1489477A Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
04/14/2004 | CN1489476A Method of preparing biological materials and preparation produced using same |
04/14/2004 | CN1489474A Monoclonal antibodies to CLFA protein and method of use in treating or preventing |
04/14/2004 | CN1489472A Improved mycoplasma hyopneumoniae bacterin vaccine |
04/14/2004 | CN1489470A Use of adenosine A3 receptor agonist for inhibition of viral replication |
04/14/2004 | CN1489465A Azole compounds as anti-fungals agents |
04/14/2004 | CN1488761A A double-stranded DNA molecule and its use in preparing medicine for inhibiting hepatitis B virus replication |
04/14/2004 | CN1488646A SARS virus S protein and N protein fusion protein, and preparation and use thereof |
04/14/2004 | CN1488645A Specific antibody IgY for anti SARS virus, and preparing method thereof and composition containing same and its use |
04/14/2004 | CN1488641A Polypeptide medicine for inhibiting SARS coronavirus, and derivatives and use thereof |
04/14/2004 | CN1488637A Method for preparing total aglycone extract of radix picrorrhizae |
04/14/2004 | CN1488634A Rare earth heteropolyacid salt anti SARS virus medicine and synthesizing method thereof |
04/14/2004 | CN1488633A Large ring lactone antibiotic and preparing method thereof |
04/14/2004 | CN1488630A Method for preparing triazole antifungal agent |
04/14/2004 | CN1488629A Method for preparing triazole antifungal agent |
04/14/2004 | CN1488381A Artichoke leaf cream extracting technique |
04/14/2004 | CN1488380A Use of chinese medicine composition in preparing medicine for anti SARS virus |
04/14/2004 | CN1488379A Tenuifolia volatile oil, and formulation preparing method and use in preparing medicine for anti-cold thereof |
04/14/2004 | CN1488378A SARS epidemic-removing pill |
04/14/2004 | CN1488376A Medicinal cap sule for treating enteric disease and nusosinusitis and preparing method thereof |
04/14/2004 | CN1488372A Chinese medicine formual for treating heptitis |
04/14/2004 | CN1488357A Medicine for treating phthisis-zheyin capsule and process technique |
04/14/2004 | CN1488349A Aspartic acid lomefloxacin powder and preparing method thereof |
04/14/2004 | CN1145697C 治疗和诊断组合物 Therapeutic and diagnostic compositions |
04/14/2004 | CN1145696C Antifungal proteins |
04/14/2004 | CN1145695C Antifungal protein |
04/14/2004 | CN1145693C Amino-terminally truncated MCP-2 as chemokine antagnosits |
04/14/2004 | CN1145639C Subunit respiratory syncytial virus vaccine preparation |
04/14/2004 | CN1145637C Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
04/14/2004 | CN1145636C C-4'-substituted macrolide derivatives |
04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
04/14/2004 | CN1145492C Metal/thiol biochdes |
04/14/2004 | CN1145491C Acidified nitrite as an antimicrobial agent |
04/13/2004 | US6720409 Anti-human influenza virus antibody |
04/13/2004 | US6720353 Purified plant proanthocyanidin extract, capable of inhibiting agglutination of P-type Escherichia coli and not capable of inhibiting agglutination of type 1 Escherichia coli; proanthocyanidin having 4-12 epicatechin flavanoid units |
04/13/2004 | US6720346 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation |
04/13/2004 | US6720327 Lactone integrin antagonists |
04/13/2004 | US6720325 CCR5 antagonists useful for treating aids |
04/13/2004 | US6720319 Compounds useful as reversible inhibitors of cysteine proteases |
04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
04/13/2004 | US6720308 Anhydrolide derivatives having antibacterial activity |
04/13/2004 | US6720010 Composition having antihepatitic activity |
04/13/2004 | US6720009 Matrix protein compositions for treating infection |
04/13/2004 | US6719986 Fermented by microorganisms; skin disorders; aging and wrinkle resistance |
04/13/2004 | US6719981 Stable, attenuated rabies virus mutants and live vaccines thereof |
04/13/2004 | US6719980 Vaccines, diagnostic kits, veterinary medicine |
04/13/2004 | US6719979 Avian-paramyxovirus nucleotide sequences for use in the detection and treatment of avian viral diseases |
04/13/2004 | US6719978 Virus-like particles for the induction of autoantibodies |
04/08/2004 | WO2004029192A2 Producing method of tien hsien liquid |
04/08/2004 | WO2004029092A2 Antibody for adcc and inducing cytokine production |
04/08/2004 | WO2004029067A1 New 3-decladinosyl derivatives of 9-deoxo-9a-aza-9a-homoerythromycin a 9a,11-cyclic carbamates |
04/08/2004 | WO2004029066A2 Bifunctional heterocyclic compounds and methods of making and using same |
04/08/2004 | WO2004029054A1 Novel adenine compound and use thereof |
04/08/2004 | WO2004029051A1 Pyrazole amides for treating hiv infections |
04/08/2004 | WO2004029042A1 Pyrazole derivatives as reverse transcriptase inhibitors |
04/08/2004 | WO2004028567A1 Drug absorbability improving agents |
04/08/2004 | WO2004028564A2 Treatment of pathologies which escape the immune response, using optimised antibodies |
04/08/2004 | WO2004028562A2 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
04/08/2004 | WO2004028561A1 Method of inducing immune responses |
04/08/2004 | WO2004028557A1 Stabilized protein compositions |
04/08/2004 | WO2004028520A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
04/08/2004 | WO2004028519A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
04/08/2004 | WO2004028502A1 Cleansing composition containing antifungal agent and antibacterial agent |
04/08/2004 | WO2004028481A2 Nucleoside derivatives for treating hepatitis c virus infection |
04/08/2004 | WO2004028478A2 Functional mutations in respiratory syncytial virus |
04/08/2004 | WO2004016613A3 Purine derivatives and their use as antiproliferative agents |
04/08/2004 | WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses |
04/08/2004 | WO2004014396A9 Medicament comprising fluocinolone and dexamethasone and/or hydrocortisone and gentamicin and/or neomycin |
04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
04/08/2004 | WO2004011454A3 Quinolyl propyl piperidine derivatives, preparation method and intermediates and compositions containing same |
04/08/2004 | WO2004009061A3 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
04/08/2004 | WO2004007512A3 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
04/08/2004 | WO2004005350A3 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |